Patrangsit Healthcare Group PCL (BKK:PHG)
Thailand · Delayed Price · Currency is THB 10.10
0.00 (0.00%)
At close: Jun 12, 2026
BKK:PHG Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,488 | 2,507 | 2,273 | 2,138 | 2,040 | 1,971 |
| 2,488 | 2,507 | 2,273 | 2,138 | 2,040 | 1,971 | |
Revenue Growth (YoY) | 7.12% | 10.29% | 6.32% | 4.81% | 3.49% | 26.71% |
Cost of Revenue | 1,885 | 1,880 | 1,738 | 1,565 | 1,432 | 1,341 |
Gross Profit | 602.42 | 627.06 | 534.62 | 573.31 | 607.98 | 630.14 |
Selling, General & Admin | 291.85 | 281.85 | 258.07 | 261.68 | 241.66 | 231.17 |
Operating Expenses | 291.85 | 281.85 | 258.07 | 261.68 | 241.66 | 231.17 |
Operating Income | 310.57 | 345.21 | 276.54 | 311.63 | 366.32 | 398.97 |
Interest Expense | -0.59 | -0.53 | -1.16 | -9.78 | -11.95 | -12.3 |
Interest & Investment Income | 30 | 30 | 30 | 30 | 20.1 | 10.2 |
Earnings From Equity Investments | -0.03 | -0.03 | -0.06 | -0.03 | - | - |
Other Non Operating Income (Expenses) | 4.91 | 12.82 | 9.95 | -7.26 | -6.59 | 3.84 |
Pretax Income | 344.87 | 387.48 | 315.27 | 324.56 | 367.89 | 400.71 |
Income Tax Expense | 69.4 | 78.01 | 63.04 | 65.09 | 74.78 | 83.23 |
Net Income | 275.47 | 309.47 | 252.24 | 259.47 | 293.1 | 317.48 |
Net Income to Common | 275.47 | 309.47 | 252.24 | 259.47 | 293.1 | 317.48 |
Net Income Growth | 4.27% | 22.69% | -2.79% | -11.47% | -7.68% | 203.41% |
Shares Outstanding (Basic) | 300 | 300 | 300 | 273 | 118 | 100 |
Shares Outstanding (Diluted) | 300 | 300 | 300 | 273 | 118 | 100 |
Shares Change (YoY) | - | - | 9.92% | 131.09% | 18.10% | - |
EPS (Basic) | 0.92 | 1.03 | 0.84 | 0.95 | 2.48 | 3.17 |
EPS (Diluted) | 0.92 | 1.03 | 0.84 | 0.95 | 2.48 | 3.17 |
EPS Growth | 4.27% | 22.69% | -11.56% | -61.69% | -21.83% | 203.41% |
Free Cash Flow | 238.87 | 298.39 | 213.32 | 245.47 | 256.13 | 260.9 |
Free Cash Flow Per Share | 0.80 | 0.99 | 0.71 | 0.90 | 2.17 | 2.61 |
Dividend Per Share | 0.700 | 0.700 | 0.500 | 0.520 | 2.361 | 1.700 |
Dividend Growth | 40.00% | 40.00% | -3.85% | -77.98% | 38.90% | -32.00% |
Gross Margin | 24.21% | 25.01% | 23.52% | 26.82% | 29.81% | 31.97% |
Operating Margin | 12.48% | 13.77% | 12.17% | 14.58% | 17.96% | 20.24% |
Profit Margin | 11.07% | 12.34% | 11.10% | 12.14% | 14.37% | 16.11% |
Free Cash Flow Margin | 9.60% | 11.90% | 9.38% | 11.48% | 12.56% | 13.24% |
EBITDA | 407.72 | 441.17 | 358.94 | 381.73 | 428.22 | 461.24 |
EBITDA Margin | 16.39% | 17.60% | 15.79% | 17.85% | 20.99% | 23.40% |
D&A For EBITDA | 97.15 | 95.96 | 82.39 | 70.11 | 61.9 | 62.27 |
EBIT | 310.57 | 345.21 | 276.54 | 311.63 | 366.32 | 398.97 |
EBIT Margin | 12.48% | 13.77% | 12.17% | 14.58% | 17.96% | 20.24% |
Effective Tax Rate | 20.12% | 20.13% | 19.99% | 20.05% | 20.33% | 20.77% |
Revenue as Reported | 2,523 | 2,550 | 2,313 | 2,161 | 2,053 | 1,985 |